JPH0251403B2 - - Google Patents

Info

Publication number
JPH0251403B2
JPH0251403B2 JP58001043A JP104383A JPH0251403B2 JP H0251403 B2 JPH0251403 B2 JP H0251403B2 JP 58001043 A JP58001043 A JP 58001043A JP 104383 A JP104383 A JP 104383A JP H0251403 B2 JPH0251403 B2 JP H0251403B2
Authority
JP
Japan
Prior art keywords
thiaprostaglandin
drug
pentanol
cyclohexyl
transdermal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58001043A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59128327A (ja
Inventor
Seiji Kurozumi
Toshio Tanaka
Atsuo Hasato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP104383A priority Critical patent/JPS59128327A/ja
Publication of JPS59128327A publication Critical patent/JPS59128327A/ja
Publication of JPH0251403B2 publication Critical patent/JPH0251403B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP104383A 1983-01-10 1983-01-10 ７−チアプロスタグランジンｅ↓１類を有効成分とする経皮投与用薬剤 Granted JPS59128327A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP104383A JPS59128327A (ja) 1983-01-10 1983-01-10 ７−チアプロスタグランジンｅ↓１類を有効成分とする経皮投与用薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP104383A JPS59128327A (ja) 1983-01-10 1983-01-10 ７−チアプロスタグランジンｅ↓１類を有効成分とする経皮投与用薬剤

Publications (2)

Publication Number Publication Date
JPS59128327A JPS59128327A (ja) 1984-07-24
JPH0251403B2 true JPH0251403B2 (OSRAM) 1990-11-07

Family

ID=11490527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP104383A Granted JPS59128327A (ja) 1983-01-10 1983-01-10 ７−チアプロスタグランジンｅ↓１類を有効成分とする経皮投与用薬剤

Country Status (1)

Country Link
JP (1) JPS59128327A (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677073B2 (en) * 1993-06-18 1997-04-10 Teijin Limited Blood vessel thickening inhibitor and smooth muscle fiber migration inhibitor each containing 7-thiaprostaglandin e1 compound as active ingredient
CA2159224A1 (en) * 1994-01-28 1995-08-03 Nobuaki Hanajima Prostacyclin-containing oleaginous ointment
US7888392B2 (en) 2005-02-14 2011-02-15 Taisho Pharmaceutical Co., Ltd. Ointment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions

Also Published As

Publication number Publication date
JPS59128327A (ja) 1984-07-24

Similar Documents

Publication Publication Date Title
US5973002A (en) Prostaglandin E1 derivatives as pharmacologically active agents, especially for transcutaneous administration
JP2991733B2 (ja) 乾癬疾患を抑制するための薬剤及びその製法
JPH0219805B2 (OSRAM)
JP2853902B2 (ja) プロスタサイクリン類を活性成分として含有する外用皮膚血流量増加剤
US20140235665A1 (en) Anti-constipation composition
JPH02706A (ja) 水性医薬製剤
HU206110B (en) Process for producing azelatine salts with improved solubility and pharmaceutical compositions comprising same
JP2001525803A (ja) 勃起機能不全治療用の薬剤の調製のためのミソプロストール及び／又はミソプロストール酸の用途
JPH082789B2 (ja) タモキシフエン又はその製薬上認容性塩を含有する乾癬の治療剤
JP2650756B2 (ja) 皮膚および粘膜上皮の疾患の治療のための４‐キノリンカルボン酸誘導体
JPH0447649B2 (OSRAM)
AU649130B2 (en) Pharmaceutical compositions for transcutaneous administration
WO2008088816A1 (en) Adenosine derivative formulations for medical imaging
JPS61118315A (ja) ステロイド−１７−モノエステル含有クリ−ム剤
JP2002534389A (ja) 女性性機能障害の治療のための方法および組成物
JPH0251403B2 (OSRAM)
WO1995022323A1 (en) Methods for controlling free radical generation by inflammatory cells
JPH03173816A (ja) アムスロシン外用剤
JPH10298077A (ja) 心筋症の治療、予防剤
EP0038567B1 (en) Deazapurine nucleoside, formulations thereof, and use thereof in therapy
EP0656889B1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
JPS61180785A (ja) 新規な治療用組成物
JPH0544467B2 (OSRAM)
RU2225208C1 (ru) Фармацевтическая композиция, обладающая противовоспалительным и антиаллергическим действием
JP3038519B2 (ja) 創傷治癒促進剤